| NDC包装代码 | 产品NDC | 产品类型 | 商品名 | 通用名 | 剂型 | 给药途径 | 上市日期 | 结束日期 | 市场类别 | 申请号 | 标签持有者 | 活性成分 | 规格 | 包装描述 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 42571-416-01 | 42571-416 | HUMAN PRESCRIPTION DRUG | Metolazone | Metolazone | TABLET | ORAL | 20250301 | N/A | ANDA | ANDA217563 | Micro Labs Limited | METOLAZONE | 2.5 mg/1 | 100 TABLET in 1 CONTAINER (42571-416-01) |
| 42571-416-10 | 42571-416 | HUMAN PRESCRIPTION DRUG | Metolazone | Metolazone | TABLET | ORAL | 20250301 | N/A | ANDA | ANDA217563 | Micro Labs Limited | METOLAZONE | 2.5 mg/1 | 1000 TABLET in 1 CONTAINER (42571-416-10) |
| 42571-418-01 | 42571-418 | HUMAN PRESCRIPTION DRUG | Metolazone | Metolazone | TABLET | ORAL | 20250301 | N/A | ANDA | ANDA217563 | Micro Labs Limited | METOLAZONE | 10 mg/1 | 100 TABLET in 1 CONTAINER (42571-418-01) |
| 42571-418-10 | 42571-418 | HUMAN PRESCRIPTION DRUG | Metolazone | Metolazone | TABLET | ORAL | 20250301 | N/A | ANDA | ANDA217563 | Micro Labs Limited | METOLAZONE | 10 mg/1 | 1000 TABLET in 1 CONTAINER (42571-418-10) |
| 42571-417-01 | 42571-417 | HUMAN PRESCRIPTION DRUG | Metolazone | Metolazone | TABLET | ORAL | 20250301 | N/A | ANDA | ANDA217563 | Micro Labs Limited | METOLAZONE | 5 mg/1 | 100 TABLET in 1 CONTAINER (42571-417-01) |
| 42571-417-10 | 42571-417 | HUMAN PRESCRIPTION DRUG | Metolazone | Metolazone | TABLET | ORAL | 20250301 | N/A | ANDA | ANDA217563 | Micro Labs Limited | METOLAZONE | 5 mg/1 | 1000 TABLET in 1 CONTAINER (42571-417-10) |